Venture Life Adds to Treasury Stock Under Ongoing Share Buyback

An update from Venture Life ( (GB:VLG) ) is now available.

Venture Life Group, a UK-headquartered consumer healthcare company specialising in self-care and healthy longevity products sold through retail and e-commerce channels worldwide, offers a portfolio including Balance Activ, Earol, Lift, Glucogel and Health & Her, which are typically recommended by pharmacists and healthcare practitioners. The Group serves markets in the UK, Ireland and the U.S. directly, while relying on distribution partners elsewhere to reach global consumers.

The company has repurchased 77,011 ordinary shares at a volume-weighted average price of 68.93 pence per share under its ongoing share buyback programme, with the shares to be held in treasury rather than cancelled. Following this transaction, Venture Life has 128,860,145 ordinary shares in issue, of which 5,635,224 are held in treasury, leaving 123,224,921 voting rights outstanding, a change that may affect shareholder notification thresholds under FCA disclosure rules and signals ongoing capital management activity by the Group.

The most recent analyst rating on (GB:VLG) stock is a Hold with a £67.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.

Spark’s Take on GB:VLG Stock

According to Spark, TipRanks’ AI Analyst, GB:VLG is a Neutral.

Venture Life’s stock score is primarily supported by strong technical indicators and positive corporate events, such as share buybacks and insider buying, which suggest confidence in future prospects. However, the high P/E ratio and profitability challenges weigh down the score, indicating potential overvaluation and financial risks.

To see Spark’s full report on GB:VLG stock, click here.

More about Venture Life

Venture Life Group is an international consumer self-care company focused on proactive healthy longevity within the global consumer healthcare sector. Headquartered in the UK, it develops and commercialises products such as Balance Activ for women’s intimate healthcare, Earol for ENT care, Lift and Glucogel for energy and glucose management, and Health & Her for hormonal health, selling mainly through pharmacies, health and beauty retailers, grocery chains and e-commerce, both directly in key markets and via international distribution partners.

Average Trading Volume: 329,883

Technical Sentiment Signal: Buy

Current Market Cap: £84.77M

See more data about VLG stock on TipRanks’ Stock Analysis page.